Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (41)

« Back to Publications

efined model for the TSG-6 link module in complex with hyaluronan: use of defined oligosaccharides to probe structure and function.

Higman VA. et al, (2014), J Biol Chem, 289, 5619 - 5634

HYALURONIDASE TREATMENT OF SYNOVIAL FLUID CAN IMPROVE MEASURED SIGNAL BY MULTIPLEX IMMUNOASSAY PLATFORMS

Jayadev C. et al, (2013), OSTEOARTHRITIS AND CARTILAGE, 21, S81 - S81

Down regulation of SCARA5 modulates bone density through increased osteoblast activity

Mahoney DJ. et al, (2013), INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 94, A13 - A13

TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin

Mahoney DJ. et al, (2013), INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 94, A32 - A33

Hyaluronidase treatment of synovial fluid to improve assay precision for biomarker research using multiplex immunoassay platforms.

Jayadev C. et al, (2012), J Immunol Methods, 386, 22 - 30

Hyaluronidase treatment of synovial fluid to improve assay precision for biomarker research using multiplex immunoassay platforms

Jayadev C. et al, (2012), Journal of Immunological Methods

Monocyte-derived tumour necrosis factor stimulated gene-6 (TSG-6) alters bone mass via effects on osteoblasts and osteoclasts

Afrough S. et al, (2012), IMMUNOLOGY, 137, 276 - 276

TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin.

Mahoney DJ. et al, (2011), Arthritis Rheum, 63, 1034 - 1043

TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin.

Mahoney DJ. et al, (2011), Arthritis Rheum, 63, 1034 - 1043

TSG-6: AN AUTOCRINE REGULATOR OF INFLAMMATORY JOINT DISEASE?

Swales C. et al, (2010), RHEUMATOLOGY, 49, I27 - I27

DOES LIGHT PLAY A ROLE IN THE PATHOGENESIS OF INFLAMMATORY JOINT DESTRUCTION?

Swales C. et al, (2009), RHEUMATOLOGY, 48, I8 - I8

The role of light in the pathogenesis of inflammatory joint destruction

Mahoney DJ. et al, (2009), BONE, 44, S325 - S325

TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.

Mahoney DJ. et al, (2008), J Biol Chem, 283, 25952 - 25962

TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assembly.

Kuznetsova SA. et al, (2008), Matrix Biol, 27, 201 - 210

TSG-6: a new regulator of bone remodelling

Day AJ. et al, (2008), INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 89, A22 - A22

Load More